Khosla, VCs plow US$100m into blood test startup using AI
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Coke’s new cane-sweetened soda risks upending sugar supplies
The move is hardly an outlandish idea.
On the Money: Butter, Meat, Water, and more
Pricey butter, quality meat, and some water, what more do you need in NZ?
Eden Bradfield: The pros and cons of Sky’s big deal
You'd best hope streaming and advertising revenue make up for the $1 purchase.
Global real estate without the passport or paperwork
A global ETF offers access to income-generating real estate like data centres, healthcare and logistics warehouses – all in New Zealand dollars.
‘Make Today the Day’: Why on-the-job training is the key to NZ’s service recovery
Covid gutted New Zealand’s service workforce. Training is the fix – and the future.
